Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Pharmaceutical Price Regulation Scheme

Department of Health written question – answered on 4th March 2016.

Alert me about debates like this

Photo of Justin Madders Justin Madders Shadow Minister (Health)

To ask the Secretary of State for Health, pursuant to the Answer of 9 February 2016 to Question 25939, what proportion of the income from estimated Pharmaceutical Price Regulation Scheme payments for 2016-17 will be brought forward from estimated payments due in (a) 2017-18 and (b) 2018-19.

Photo of Ben Gummer Ben Gummer The Parliamentary Under-Secretary of State for Health

The Government announced in December 2015 that the Pharmaceutical Price Regulation Scheme (PPRS) payment percentage for the 2016 calendar year is 7.80%. This represents an increase of 2.64 percentage points as a result of the addendum to the PPRS agreed with the Association of the British Pharmaceutical Industry and published alongside the 2016 payment percentage. The income brought forward to 2016 as a result of this agreement will depend on a number of factors, including total branded medicine sales to the National Health Service over the course of the year.

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.